Tag Archives: startup

Senate Passes Legal Framework for Startups, Dangers of Privatization, Costs of 5G | Instant News

Welcome to this week’s gathering of Brazilian technology and innovation. Here are three major developments in Latin America’s largest economy: first, the main story from this week is this: The Brazilian Senate has issued a legal framework for startups. Subsequently, the government was warned about the dangers of the impending sale of state-owned technology companies, and the estimated 5G costs for operators were announced.

Senate Passes Legal Framework For Startups

The Brazilian Senate has passed the Legal Framework for Startups, which establishes a regulatory environment to stimulate the formation of innovative companies and provide incentives for those who invest in new technology-based companies.

Approved unanimously on Thursday (25), the latest version of the framework underwent significant changes in light of what Congress passed last December. After months of lobbying, players in the Brazilian startup ecosystem perceive the latest version of the framework as a step backwards despite the clarity the framework brings to a number of areas.

Among the highlights, the framework establishes safeguards for investor rights, as well as the establishment of a special government purchasing regime that simplifies the process for startups to compete for public sector contracts. On the other hand, the framework has pressed a number of points that the startup community deems necessary to promote segment development, as well as the ability of startups to establish themselves under a simplified tax regime. Another key point that has been excluded from the version approved by the Senate is the use of stock options to reward employees in exchange for cash.

The Legal Framework for Startups now returns to Congress, where changes made by the Senate will be either approved or vetoed, preventing discussions from moving forward.

The sale of serpro can jeopardize national security

Brazilian Ministry of Economy was warned about the potential national security risk associated with the upcoming sale of Federal Data Processing Service (Serpro). The hazards have been described in documents sent to Public Prosecutor Service in relation to state-owned companies, which will be sold in 2021 as part of a national privatization plan. Serpro handles all kinds of sensitive data on behalf of the government, ranging from processing tax returns of the entire population, to developing critical systems used by the Armed Forces.

The document poses a range of questions focused on the future of data that Serpro is dealing with in the privatization scenario. Among the points raised, the Prosecution argued that the current general data protection regulations in Brazil prevent data related to public and national security and defense from being handled by private sector organizations. In addition, he argues that handing over sensitive data or disclosing details about data processing automation technologies or platforms to governments or companies is a threat to national security.

“In the privatization process, Serpro can be controlled by a foreign company, so that foreign governments can control it directly or indirectly, have access to data and technology that is being developed in Brazil which is important for its defense, security and economy,” he said. Documents have been sent to National Auditor Court and to National Development Bank (BNDES), who are currently working on privatization plans for Serpro and Dataprev, the technology company responsible for Brazil’s social security system, will also go on sale later this year.

The cost of 5G in Brazil exceeds US $ 6 billion

Brazil’s national telecommunications agency Anatel have agreed the contents of the notification for the coming country 5G auction. The agency estimates the opportunity cost “for operators will be up to 35 billion reais (US $ 6.2 billion) to use the 3.5 GHz frequency band. In addition, companies will need to invest an additional 80 billion reais (US $ 14 billion) in 5G over 20 the next year.

The mandatory investment is the allocation of resources that operators need to set aside for deploying fiber optics in locations in the North and Northeast which remain digitally excluded, as well as cellular connectivity to 14,000 locations across the country. Additionally, telecommunications companies will need to connect all federal highways to the mobile internet, deploy fiber-optic cables that will traverse the Amazon rainforest, and launch communications networks for exclusive use by the government.


image source

The future of startup cryptocurrency Ripple hangs on the SEC’s case | Instant News

Brad Garlinghouse, Ripple’s chief executive, last year publicly contemplated at the World Economic Forum in Davos, Switzerland, the initial public offering for the San Francisco startup.

The company recently raised about $ 200 million in a venture funding round led by Tetragon Financial Group, with a valuation of $ 10 billion. The value of its flagship product, a cryptocurrency called XRP, has fallen over the previous year. But Ripple is poised to rebuild the infrastructure for cross-border trade, said Garlinghouse, promising that its future is bright.

A year later, the IPO was canceled. Instead, Ripple’s future hinges on the judge’s decision in a civil suit filed in December by the Securities and Exchange Commission.

Regardless of the outcome, this case is expected to set a major precedent for how US regulators create rules and laws covering cryptocurrencies. It also highlights a broader truth about most digital currencies: Beyond the two largest, bitcoin and ether, most of the hundreds of others have struggled to find utilitarian value beyond speculation.

At the heart of the SEC’s suit is the debate about XRP, a bitcoin-like digital asset created by the founder of Ripple that will grow to become the world’s third-largest cryptocurrency. It is designed to be part of a network that will help banks cut costs in cross-border transfers. The related software, however, never gained traction, the SEC accused, leaving XRP with no apparent purpose, other than to funnel sales to Ripple.


image source

Fewer global investors are only funding startups this year | Instant News

The number of new global investors fell to 24 from 71 last year, even as US-based companies continue to lead, according to data from Venture Intelligence.

Since April, when the government imposed strict restrictions on investment from countries where India shares a land border, namely China, the number of new Chinese investors has also dropped to 2 versus 5 in 2019.

South Korea, Germany, Hong Kong, Switzerland, where new investors supported many startups last year, made no new commitments this year.

Analysts believe that the pace of funding will increase over the next month, with more interest from investors in Southeast and West Asia, especially in the fields of gaming, agri-tech, health, fitness and others.

In October, local language gaming platform WinZO raised $ 18 million in a Series B funding round led by Singapore-based Makers Fund and New York-based Courtside Ventures, along with existing investors such as Kalaari Capital. For Makers and Courtside, this is their first investment in India.

“Courtside Ventures is excited about the growth and scale of the Indian market. We believe that there are extraordinary opportunities in games, fitness and sports. We are investing from Seed to Series B and hope to continue our investment in 2021, “said a spokesperson.

Foreign investors are starting to show interest following a surge in the number of Indians using the internet, as people adopt a digital way of life amid the disruption caused by the pandemic.

Nitish Poddar, partner and national leader, private equity, KPMG in India, said the impact of the pandemic played a big role as investors were unsure which direction this would take and therefore the first quarter failed.

“However, we have seen activity after everything is sorted out through a number of edtech transactions and delivery of staple goods. When things open up and the impact of the pandemic on various subsectors becomes clearer, hidden activities will gather energy and will result in busy activities in the startup space. There is continuing interest in Indian startups and we have just touched the tip of the iceberg in my view, “said Poddar.

Apart from e-commerce and edtech, which have seen great traction as shopping and learning moved online, software as a service (SaaS), e-business to business and logistics have also attracted investors as they are ready to face digital disruption and have leverage. the big one. market potential and the ability to measure.

Earlier this month, American Family Ventures and US-based MassMutual Ventures supported the Turtlemint insuretech platform.

Charles Svirk, principal at MassMutual Ventures, said when funding was announced this month that the impact of the pandemic has reinforced the importance of adopting digital processes and Turtlemint’s vision will drive significant growth and seamless experiences across industries.

Bengaluru-based payment gateway platform JusPay raised $ 21.6 million led by Sweden-based Vostok Emerging Finance (VEF) with an investment of $ 13 million.

“China’s application ban for additional approval required for Chinese investment has had an impact on Indian startups. However, on this account there is greater investment interest from Southeast Asia, the Middle East region either directly (through state funds) or by co-investing with local funds, “Ankur Pahwa, partner and national leader, e-commerce and consumer Internet, EY India.

While American investors have always favored India, and may wish to increase their allocation of funds to India taking into account the business environment and growth prospects in a post-pandemic world, Pahwa added that the investor class as a whole is becoming more diverse and broad-based which bodes well for India’s startup ecosystem.

Subscribe Mint Bulletin

* Please enter a valid email

* Thank you for subscribing to our newsletter.


image source

Here are four food tech trends that will still be trending in 2021 | Instant News

Michael Lavin, founder and managing partner Germin8 Ventures, said over the last decade, consumers have changed their mindset about food in interesting ways.

“We used to like convenient nutrition at a low cost, over time we became more and more concerned with clean labels and wholeness, and now consumers also want functional ingredients that support health,” says Lavin.

Lavin says that consumers are increasingly aware of the role diet plays in their health.

“Globally, chronic disease accounts for more than 70% of all deaths each year, but 80% of certain chronic conditions can be prevented through a healthier diet. Diet is the second highest risk factor for premature death after smoking, and, interestingly, it is less about poor dietary intake and more about the beneficial nutrients that are lost from our diets, “Lavin said.

“Consumers see that supplements are not a silver bullet, and they need a holistic strategy to proactively manage their health,” adds Lavin.

Data and traceability

Part of the new food and health awareness comes down to data and traceability, according to Jean Pougnier, CEO from Plant Enhancement.

“Traceability will extend beyond food safety and production methods to include aroma, taste, texture, nutritional benefits and other aspects of food quality,” said Pougnier. “Big data has evolved, but the use of that data has not evolved and will make progress in 2021.”

Pougnier added it would be imperative for small farmers in remote parts of the world who have no table seats and no long-term equity in their crops once sold to wholesalers.

Alternative and cell-based protein creation

Looking at the alternative protein market, McKinsey 2019 report On alternative protein, it was revealed that sales of plant foods increased 17 percent in 2018. In 2019, UBS estimated the plant-based protein or alternative meat market grows 28% a year to $ 85 billion by 2030.

“The past twelve months have been a period in which new players can present proof of concept to investors and media groups, said Lavin.” The next period will be marked by success and failure in optimizing flavors and formulations for scale-up. “

Lavin said cell-based proteins can refer to cultured proteins for the human market, but are also linked to alternative proteins that are produced biologically for animals, including livestock, aquaculture and companion animal markets, and each of these markets has attracted significant investment capital.

Ÿnsect is one of these companies.

Ÿnsect wants to change the food chain with insects. Company, armed with $ 425 million in funding and $ 372 M recently series C June 2020 includes investment from the FootPrint Coalition of Robert Downey Jr., converting farm-grown insects into premium animal nutrition.

“We believe that fish fed with sustainable protein (mealworms) will become certified label and then become a requirement in future aquaculture,” said Antoine Hubert, CEO, Ÿnsect.

Lavin notes that ultimately success can be overpowered by poor consumer perceptions, unfulfilled taste, sensory experiences, and cost.

“This is a sector that still needs to be industrialized, and a big part of doing so lies in designing better inputs and tools. We’ve seen many entrants develop new growth factors, media, bioprocessing hardware and software,” Lavin said.

Lavin adds that 100% plant-based and hybrid products, mostly plant-based, will ultimately win with dominant market share and consumer preference.

Increased carbon removal through nature-based agricultural projects

There are several impact pathways for agriculture to reduce or remove carbon.

Hubert of Ÿnsect says the emergence of large-scale carbon negative proteins and vertical farming is one way. “With vertical farming, we use 98% less land while significantly reducing the carbon footprint of protein production and producing zero waste,” said Hubert.

“Food systems contribute about 26% (13.6 billion tonnes) of global greenhouse gas emissions, with livestock being the highest contributor,” Lavin said. “Of the 13.6 B tonnes of CO2 equivalent, about 31% is attributed to enteric fermentation – the release of methane – and 18% to land use for livestock – this is a very significant impact pathway for startups, new technologies, and farmers to make a difference. “

Lavin notes that the most significant barrier is not the availability of technology, but the economic factors needed to stimulate adoption and shifting practices.

“The majority of methane-inhibiting feed additives and enzymes hold promise for reducing methane, but as a consequence of animal weight gain, which means a net reduction in farmer profits, and therein lies a necessary breakthrough,” adds Lavin.

“There are also proven grazing methods to create dynamics where certain swarm emissions are more than offset by carbon reabsorbed into the soil, but this regenerative strategy is not the norm for its complexity,” Lavin said. “Alternative technologies, markets and proteins will increasingly intervene in this area and make it possible to shift livestock production to a more sustainable model. This is very important.”

Food as medicine

The global Covid-19 pandemic has affected every aspect of our industry and collective way of life. Although disruption from the pandemic is slowing down investation This movement, at the same time, has also created opportunities for real business opportunities that will advance the food-as-medicine movement.

“Germin8’s view is that food technology as medicine refers to any product or service that transfers power to food as a health tool, and they exist throughout the value chain,” Lavin said. “Downstream, this could include consumer applications serving as artificial intelligence (AI) nutrition trainers, foods featuring evidence-backed active ingredients, or personalized supplements aimed at enhancing your unique microbiome in a tailored way.”

Lavin says that food-as-medicine innovations include a computational discovery platform that uncovers new nutrients to significantly strengthen our health; bioprocessing methods for producing high value nutrients at low cost; safe and reliable new chemicals for farmers to use; and farming new crops that make our diets more diverse.

“Chronic diseases are projected to have a global impact of $ 47 T by 2030, so food as medicine is a great opportunity as it gains momentum to solve this problem, and investors will continue to invest,” Lavin added.


image source

Swiss startups are betting on nanotechnology to speed up cancer diagnosis | Instant News

A Swiss startup is testing devices that rely on nanotechnology to speed up cancer diagnosis, a goal shared by many researchers and entrepreneurs around the world.

Nanotechnology is a promising approach, according to the National Cancer Institute. Apart from diagnosing cancer earlier and sooner, this has the potential to assist in making treatment decisions. The hope for a nano-oncology application is that it is also less toxic than chemotherapy.

Founded in 2017, Artidist hopes his device can do both, starting with breast, lung and pancreatic cancer, according to Marija Plodinec, co-founder and CEO of the company. Artidis employs 22 people in Switzerland and the US

The Artidis device relies on proprietary nanomechanical biomarkers and clinical data analytics to diagnose cancer in biopsied tissue.

The device – also known as Artidis – relies on proprietary nanomechanical biomarkers and clinical data analytics to diagnose cancer in biopsied tissue. Biomarkers can also measure cancer aggressiveness, allowing for customized treatment.

Results were available in less than three hours, beating the days it took after a traditional biopsy, Plodinec wrote in an emailed response to questions forwarded by a spokesperson. A cancer biophysicist, Plodinec began researching the technology used by Artidis in 2008 when he was a graduate student at the University of Basel in Switzerland.

“Breast cancer is the most common form of cancer in women and I wanted to find a device that would reduce the stressful period of uncertainty before you receive a cancer diagnosis,” wrote Plodinec.

Since its founding three years ago, Artidis has raised $ 15.1 million in seed money from investors including Bernina Bioinvest and SMD MedicalTrade AGboth based in Switzerland.

With a view to expanding in the US, Artidis hopes to raise another $ 20 million in Series A funding by the end of 2020. The company aims to enter the market by 2022 and is currently finalizing pre-submission files for submission to US Food. and Drug Administration, says Plodinec. Hospitals and health systems will be able to buy or lease accompanying devices and software, he said.

In a study involving 545 patients in Switzerland from 2016 to 2019, Artidis proved effective in detecting breast cancer in routine clinical settings. Presented at the June meeting of the American Association for Cancer Research, this study also demonstrates the potential of a tool for assessing future tumor growth.

“Secondary analysis suggests that this new technology will be able to subclassify breast cancer subtypes into more or less aggressive subgroups, which can define a patient’s treatment plan and thereby reduce over-treatment and under-treatment,” Dr. Rosemarie Burian, lead investigator of the study and a gynecologist at the Breast Center at Basel University Hospital, said in a statement announcing the results this summer.

Artidis plans to launch a multi-center study for breast cancer in the US later this year and a similar study in Europe in early 2021, Plodinec wrote. A proof-of-concept study on lung and pancreatic cancer is also scheduled to begin in early 2021.

In the US, Artidis has collaborated with MD Anderson Cancer Center at Texas Medical Center in Houston, Plodinec said, adding that the company is in talks with other US cancer centers.

“Artidis can be used to analyze any living tissue, so the potential for growth is enormous,” he wrote.

Photos: CGToolbox, Getty Images and Artidis


image source